This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder

Last updated:
2026-07-11
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO- AND ACTIVE- CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF COMBINATIONS OF SOLIFENACIN SUCCINATE AND MIRABEGRON COMPARED TO SOLIFENACIN SUCCINATE AND MIRABEGRON MONOTHERAPY IN THE TREATMENT OF OVERACTIVE BLADDER

Intervention/treatment:
SOLIFENACIN / MIRABEGRON
Medical condition:
OVERACTIVE BLADDER
Protocol code:
178-CL-101
Control number:
166448
Status:
Closed
Approved:
August 07, 2013
Date Completed:
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT01972841
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years and older
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Medical Director
Organization
Astellas Pharma Europe B.V.
Phone:
+31 (0) 71 5455 050
Sponsor
ASTELLAS PHARMA EUROPE B.V.

Locations

Alberta

Site CA15029 Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9
Site CA15035 Glenrose Rehabilitation Hospital
Edmonton, Alberta, T6G 2P4

British Columbia

Site CA15033 Prohealth
Vancouver, British Columbia, V5Z 4E1

New Brunswick

Site CA15008 Private Practice
Saint John, New Brunswick, E2L 3J8

Ontario

Site CA15001 The Male/Female Health & Research Centre
Barrie, Ontario, L4M 7G1
Site CA15002 Toronto Western Hospital
Toronto, Ontario, M5T 2S8
Site CA15003 Brantford Urology Research
Brantford, Ontario, N3R 4N3
Site CA15004 Primehealth Clinical Research
Toronto, Ontario, M4S 1Y2
Site CA15006 Bramalea Medical Centre
Brampton, Ontario, L6T 4S5
Site CA15007 Eunoia2 Incorporated
Kitchener, Ontario, N2N 2B9
Site CA15013 Sunnybrook Health Sciences Center
Toronto, Ontario, M4N 3M5
Site CA15031 Centre for Applied Urology Research (CAUR)
Kingston, Ontario, K7L 3J7
Site CA15032 Stanley Flax Medical Prof Corp
North York, Ontario, M2J 1V1
Site CA15034 Oxford/Richmond Medical
London, Ontario, N6A 5R9
Site CA15042 G. Kenneth Jansz Medicine Professional Corporation
Burlington, Ontario, L7N 3V2
Site CA15044 McMaster Institute of Urology
Hamilton, Ontario, L8N 4A6

Quebec

Site CA15010 Ultra Med Research, Inc.
Point-Claire, Quebec, H9R 4S3
Site CA15015 Recherches Cliniques Theradev, Inc.
Granby, Quebec, H2R1V6
Site CA15020 Diex Research Montreal
Montreal, Quebec, H4N 3C5
Site CA15021 Urology South Shore Research
Greenfield Park, Quebec, J4V 2H3
Site CA15025 Clinique RSF Inc.
Québec, Quebec, G1S 2L6
Site CA15026 Rhodin Recherche Clinique
Drummondville, Quebec, J2B 7T1
Site CA15027 Diex Research Sherbrooke Inc
Sherbrooke, Quebec, J1H 1Z1
Site CA15030 UroLaval
Laval, Quebec, H7G 2E6
Site CA15039 Pro-recherche
Saint Romuald, Quebec, G6W 5M6
Site CA15040 RechercheGCP Research
Montreal, Quebec, H2R1V6

Results

See the results from the trial NCT01972841. This is an external link. The information is not authorized by the Government of Canada.

Date posted:
Did you find what you were looking for?